World Biosimilar Congress 2017
- Start Date:
- Tuesday, 31 October, 2017
- End Date:
- Wednesday, 1 November, 2017 6:00pm
- Health & Nutrition
The 6th annual World Biosimilar Congress is coming to Basel 31st October - 1st November. Once again it will be covering all the key issues within biosimilar development, manufacture, market access and regulations, all in one jam packed two-day event.Across the two days, industry and thought-leading speakers from across the globe will come together to network and discuss the key issues on biosimilar drug development and healthcare uptake.
Key topics will include:The Global R&D and Regulatory Landscape Designing Biosimilar Development Programmes Bioanalytics for Biosimilars Characterisation and Comparison of Biosimilars to Originators Extrapolation and Interchangeability Pharmacovigilance in Biosimilars Legal Considerations for Biosimilars Biosimilar Uptake and Market Considerations Increasing Purity and yield in Biosimilar Production Speakers: Elena Wolff-Holz, Chair of the Biosimilar Medicinal Products Working Party of the CHMP (BMWP), EMA / Benedicte Lunddahl, Team Leader, Pharmacovigilance, Danish Medicines Agency / Erin Federman, Global Director, Team Lead, Immunology Biosimilars, Boehringer Ingleheim / Ingrid Schwarzenberger, Head Global Regulatory Affairs, Sandoz Biopharmaceuticals / Adam Levysohn, Sr Director Market Access Biosimilar, Biogen / Uwe Gudat, Head of Safety, Biosimilars, Merck / Margaret Dolan, Specialist Procurement Pharmacist, Procurement Team, NHS Commercial Solutions / Ber Oomen, Executive Secretary, European Specialist Nurses Organisations / Andrew J.
G. Simpso, Scientific Director, Orygen Biotecnologica / Andrew Spiegel, Executive Director, Global Colon Cancer Assn. / Anjan Selz, Vice President - Head of Biosimilars EMEA, Lupin Europe Ltd / Alain Beck, Senior Director Analytical Chemistry, CIPF and Associate Editor, mAbs / Benedicte Lunddahl, Team Leader, Pharmacovigilance, Danish Medicines Agency
Congress Center Basel,
Conference organized by Terrapinn
- +44 2070921178